Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1)

  • Bioorg Med Chem Lett. 2008 Jan 15;18(2):532-7. doi: 10.1016/j.bmcl.2007.11.084.
Sadagopan Magesh  1 ,  Setsuko Moriya ,  Tohru Suzuki ,  Taeko Miyagi ,  Hideharu Ishida ,  Makoto Kiso
Affiliations
  • 1. Department of Applied Bioorganic Chemistry, Gifu University, Gifu 501-1193, Japan. [email protected]
PMID: 18068975 DOI: 10.1016/j.bmcl.2007.11.084
Abstract

We here report the design and synthesis of selective human lysosomal sialidase (NEU1) inhibitors. A series of amide-linked C9 modified DANA (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) analogues were synthesized and their inhibitory activities against all four human sialidases (NEU1-NEU4) were determined. Structure-based approach was used to investigate the basis of selectivity of the compounds with experimentally observed activity. Results from the present study are found to be informative in a qualitative manner for the further design of isoform selective human sialidase inhibitors for therapeutic value.

Products